recombinant human granulocyte colony-stimulating factor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for recombinant human granulocyte colony-stimulating factor, covering 2011-11-28 to 2024-07-17. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases